Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Shibuya Kogyo



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
The average size of a deal this fund participated in
Portfolio companies 5
Rounds per year 0.08
Lead investments 2
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Medical Device
  • Hospital
  • Medical

In 1931 was created Shibuya Kogyo, which is appeared as Corporate Investor. The venture was found in Asia in Japan. The leading representative office of defined Corporate Investor is situated in the Kanazawa.

Among the most popular fund investment industries, there are Therapeutics, Medical. Among the various public portfolio startups of the fund, we may underline Promethera Biosciences, Cyfuse Biomedical, Healios K.K The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Japan. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Shibuya Kogyo, startups are often financed by Shire, Mitsui Global Investment, Boehringer Ingelheim Venture Fund. The meaningful sponsors for the fund in investment in the same round are tella, Shinsei Corporate Investment Limited, Shin Nippon Biomedical Laboratories (SNBL). In the next rounds fund is usually obtained by Sansei Capital Investment, SMBC Venture Capital, SBI Investment.

Opposing the other organizations, this Shibuya Kogyo works on 4 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2015. The important activity for fund was in 2018. Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Shibuya Kogyo:
Typical Co-investors
Shibuya Kogyo is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Shibuya Kogyo:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Circus Future -
Crescent Enterprises Venture Capital Sharjah, Sharjah Emirate, United Arab Emirates
First Round Finland, Riihimäki, Southern Finland
Granger Management LLC -
Korea Information Certificate Authority (KICA) -
Kvika Gullbringusysla, Iceland, Reykjavík
Leeway Ventures England, London, United Kingdom
Liangcang Accelerator China, Hangzhou, Zhejiang
Miller Center for Social Entrepreneurship California, Santa Clara, United States
Musketeer Capital Haverford, Pennsylvania, United States
Panthera Capital Ventures Dubai, United Arab Emirates
Rongyin Capital Beijing, China, Haidian
Shanghai Houting Management Consulting China, Shanghai
The Eleos Foundation California, Santa Barbara, United States
Thominvest Finland, Helsinki, Southern Finland
TIM Italy, Lazio, Roma
Topfonds Gelderland -
V-Capital China, Shanghai
Vilitas GmbH & Co. KG Aachen, Germany, Nordrhein-Westfalen
zkValidator -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Noile-Immune Biotech

$21M22 Mar 2021 Chiyoda, Japan


Health Care
$7M30 Jul 2018 Japan, Chiyoda

Health Care
Medical Device
$12M02 Mar 2015 Chiyoda, Japan


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Shibuya Kogyo?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 13M
Rounds per year 0.08
Peak activity year 2018
Lead investments 2
Follow on index 0.17
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Noile-Immune Biotech

$21M22 Mar 2021 Chiyoda, Japan


Health Care
$7M30 Jul 2018 Japan, Chiyoda

Health Care
Medical Device
$12M02 Mar 2015 Chiyoda, Japan
Crunchbase icon

Content report

The following text will be sent to our editors: